Abstract
Aim
Diabetes mellitus is associated with a poor prognosis due to a high rate of coronary artery disease. It was the aim of this survey to assess the prevalence of an impaired glucose tolerance and manifest diabetes mellitus in patients with coronary artery disease (CAD).
Methods
We analyzed data of all German centers participating in the Euro Heart Survey on diabetes and the heart, an European-wide multicenter prospective observational study. Participating centers were asked to recruit patients >18 years with a diagnosis of CAD.
Results
In Germany, 261 patients with a diagnosis of CAD were enrolled in five participating centers. Patients were divided into an acutely (22,4%; n = 57) or electively admitted (77,6%; n = 198) group. There were 34% (n = 89) of patients with already known diabetes. In 36% (n = 22 of 56) of the patients without previously known diabetes, an oral glucose tolerance test (OGTT) was performed (3%, n = 5 in the acute and 33%, n = 51 in the elective group). As a result, 39% (n = 22 of 56) of these patients had an impaired glucose tolerance (acute group: 0%, n = 0 of 5; elective group: 43%, n = 22 of 51) and in 13% (n = 7 of 56) diabetes mellitus was diagnosed (acute group: 40%, n = 2 of 5; elective group: 10%, n = 5 of 51). Furthermore, on admission 86% of women and 94% of men reported to exercise less than three times per week and thus less than recommended in current guidelines.
Conclusion
More than one third of the patients with CAD who underwent an OGTT had an impaired glucose tolerance. Implementation of this simple, effective and inexpensive test into clinical routine of patients with CAD would help diagnose diabetes mellitus and thus grant these high risk patients access to an optimal medical, interventional and surgical therapy. Furthermore, patients ought to be encouraged to include exercise training into their daily routine.
Similar content being viewed by others
References
Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553
Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L (2004) Newly detected abnormal glucose tolerance: an important predictor of long-termoutcome after myocardial infarction. Eur Heart J 25(22):1990–1997
Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl E, Soler Soler J, Ohrvik J, Euro Heart Survey Investigators (2004) The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25:1880–1890
Bischoff B, Silber S, Richartz BM, Pieper L, Klotsche J, Wittchen HU, DETECT Study-Group (2006) Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany. Clin Res Cardiol 95(8):405–412
Gohlke H, Kübler W, Mathes P, Meinertz T, Schuler G, Gysan DB, Sauer G, Germans Society of Cardiologiy (2005) Position paper on the primary prevention of cardiovascular diseases. Z Kardiol 94(Suppl 3):III/113–III/115
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and innondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339(4):229–234
Lankisch M, Futh R, Schotes D, Rose B, Lapp H, Rathmann W, Haastert B, Gulker H, Scherbaum WA, Martin S (2006) High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol 95(2):80–87
Leschke M, Schwenk B, Bollinger C, Faehling M (2006) Impaired glucose metabolism in patients with ischaemic heart disease. Clin Res Cardiol 95(Suppl 1):i98–i102
Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L (1995) Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26(1):57–65
Niebauer J, Sixt S, Zhang F, Yu J, Sick P, Thiele H, Lauer B, Schuler G (2004) Impact of diabetes mellitus type 2 on in-hospital outcome after cardiac catheterisation in a large cohort of octogenarians. Int J Cardiol 96:441–446
Niebauer J (2006) Evidenz-basierte Anwendung und Leitlinien-gemäβe Dosierung des Therapeutikums Sport: Körperliches Training bei Diabetes mellitus Typ 2. Univers Inn Med 6:30
Niebauer J, Weitgasser R (2007) Leitlinie Diabetes mellitus Typ 2—Lebensstil: Diagnostik und Therapie. Wien Klein Wochenschr 119/15–16(Suppl 2):10–11
No authors listed (2000) Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21(18):1502–1513
Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Ryden L, Wallentin L (2004) Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 43(4):585–591
Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359(9324):2140–2144
Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D, Task Force on Diabetes, Cardiovascular Diseases of the European Society of Cardiology (ESC), European Association for the Study of Diabetes (EASD) (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European society of cardiology (ESC) and of the European association for the study of diabetes (EASD). Eur Heart J 28(1):88–136
Schächinger V, Britten MB, Zeiher AM (2006) Diabetes mellitus and coronary artery disease-a high risk combination. Clin Res Cardiol 95(Suppl 1):i18–i26
Schnell O, Schafer O, Kleybrink S, Doering W, Standl E, Otter W (2004) Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry. Diabetes Care 27(2):455–460
Schönauer M, Kautz C, Thomas A, Niebauer J (2007) Überblick: kardiale autonome diabetische neuropathie. Diabetologie 2:175–182
Sixt S, Schuler G, Niebauer J (2004) Akutelle Therapieoptionen bei diabetes mellitus Typ 2 und koronarer Herzkrankheit: Intensivierte Sekundärprävention vs. perkutane oder chirurgische Revaskularisierung. Dtsch Med Wochenschr 129:1385–1389
Taubert G, Winkelmann BR, Schleiffer T, Marz W, Winkler R, Gok R, Klein B, Schneider S, Boehm BO (2003) Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145(2):285–291
Tschöpe D (2006) Diabetics in secondary prevention. Clin Res Cardiol 95(Suppl 6):VI23–VI27
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Drechsler, K., Fikenzer, S., Sechtem, U. et al. The Euro Heart Survey – Germany: diabetes mellitus remains unrecognized in patients with coronary artery disease. Clin Res Cardiol 97, 364–370 (2008). https://doi.org/10.1007/s00392-008-0643-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-008-0643-z